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Objectives – To determine how often patients are given choice in neurology outpatient 
consultations and whether choice is associated with greater patient satisfaction. 
 
Methods – Prospective study in outpatient clinics in two United Kingdom centres. 
Interactions between 14 neurologists and 223 patients were studied. Participating doctors and 
patients completed post-appointment questionnaires asking whether choice had been offered / 
perceived. Patients completed the Medical Interview Satisfaction Scale 21 (MISS-21). 
 
Results – Choice was reported after most encounters (patients 71.8%, neurologists 67.9%). 
Patients and Neurologists failed to agree about whether choice was offered after 32% of 
consultations. Choice was not associated with increased patient satisfaction. In fact, 
satisfaction was greater when no choice had been offered (p=0.05). Satisfaction scores were 
also greater when doctors were more certain about the diagnosis and when symptoms were 
considered explained by a medical condition (p≤0.001).  
 
Conclusions – Choice featured in the majority of clinical interactions but clinicians and 
patients often disagreed whether this was the case. Choice was not associated with greater 
patient satisfaction.  
 
Practice Implications – Clinicians need to be very explicit if they want patients to know that 
they are being given choices. Choice is not necessarily valued by patients in all clinical 
interactions. 
 
 
 
 
 
 1. Introduction (revised) 
 
‘Patient choice’ has been increasingly prioritised in UK health policies over the past decade. 
Yet the very concept of patient choice is contested and used in different ways across 
academic, political and policy literatures [1]. Even within the NHS, patient choice may mean 
very different things. The NHS Choice Framework [2], for example, outlines specific 
markers of choice, such as a patient’s choice of location of care and of the clinician they see. 
In contrast, other NHS policies emphasise choice in the context of the patient’s right to 
decline treatment and to be involved in choosing test or treatment options [3]. For instance, a 
2010 Government White Paper sets out a “vision of an NHS… where ‘no decision about me, 
without me’ is the norm” [4]. Likewise, the General Medical Council (GMC, the regulatory 
body which controls the training and accreditation of doctors in the UK) has declared that 
practitioners should maximise patients’ opportunities and ability to make decisions for 
themselves [5]. Recently, the NHS 2014 Five Year Forward View announced that 
“empowering patients” is a key goal, with choice seen as central to achieving this outcome 
[6]. The issue of choice has been particularly highlighted in the management of chronic 
conditions (which make up a high proportion of neurological disorders), where patients often 
understand their diseases as well as, or better than, health professionals [7].  
 
‘Patient choice’ in the NHS is, then, multi-faceted. Not only does the focus vary (i.e. choice 
about what?), but research in this area has used diverse definitions and measures, with 
‘choice’ often embedded within broader concepts such as ‘patient-centred care’, ‘patient 
empowerment’, ‘patient involvement’ or ‘shared decision-making’ [8-11]. Moreover, despite 
the widespread claim - within the NHS and beyond - that good practice entails a more 
‘shared’ (as opposed to a more ‘paternalist’) approach, the empirical literature offers far less 
consensus. For instance, only some studies investigating the association between measures of 
patient satisfaction and shared decision-making (SDM) have found a positive correlation 
[12],, with some research suggesting that this depends on the extent to which patients have a 
preference for autonomy [13]. A systematic review of the use of decision aids “designed to 
help people make specific and deliberative choices among options” found that they improved 
patients’ knowledge of treatment options and their condition, but seemed to have “no effect 
on satisfaction with decision-making, anxiety and health outcomes” ([12] p. 220). In contrast, 
a 2001 Cochrane systematic review found that interventions designed to increase patient-
centredness generally succeeded in increasing patient satisfaction [14].  However, the same 
review found that these interventions did not necessarily produce positive health outcomes, 
with some studies showing “clear negative effects” (cited in [15], p. 1374-5).  This may 
reflect differences across demographic subgroups and patients’ presenting complaints.  For 
instance, a review of SDM in oncology concluded that, overall SDM is associated with better 
outcomes and greater patient satisfaction, however there may be variability across patient 
groups and cancer types with respect to how involved patients want to be in decision-making 
processes [16]. 
 
One of the few studies to focus explicitly on choice in the NHS [17] found that patients 
distinguished both between having a choice and making one, and between the appearance of 
choice and substantive choice.  Crucially, while patients valued having a (meaningful) 
choice, they often reported not wanting to make the final decision. In addition to this, the 
importance of personal ‘choice’ has varied cultural and social constructions. In some cultures 
choice is conceptualised as essential to autonomy and fundamental to well-being [18], while 
in others it may  be less valued as a contributor to happiness [19]. This type of difference may 
make it difficult to draw general conclusions relating to choice where patients are culturally 
and ethnically diverse. The acknowledgment of variability amongst patients and types of 
choices complicates the argument that offering ‘more choice’ is necessarily better for all; 
arguably, the rights of patients to opt out of greater involvement in decision-making ought to 
be treated with as much respect as those of patients whose desires and values are in line with 
current policies on patient choice [20].  
 
In an attempt to address some of these issues, we previously conducted a large, prospective 
conversation analytic study which was primarily designed to determine whether and how 
choice (regarding treatments and investigations) is implemented in two outpatient neurology 
settings [21]. The current study further explores these data, to try and assess how often 
clinicians offer such choice during consultations and how frequently neurology patients 
perceive it as having been offered. Secondly, we measure the degree to which patients 
actually value being offered choice by clinicians, by assessing the influence that the 
perception of such choice has on patient satisfaction. In our analyses we consider the effects 
of neurologists’ certainty about the diagnosis, agreement with the patient (eg. about choice), 
and the extent to which neurologists consider the presenting symptoms ‘medically explained’ 
on patients’ satisfaction with their interaction with the doctor, because these features have 
been found to correlate with patient satisfaction with decision-making or satisfaction more 
generally in some previous studies  [22-25].   
 
2. METHODS 
 
 
2.1 Participants  
 
This prospective, multicentre study was conducted in neurology outpatient clinics at the 
Southern General Hospital in Glasgow and the Royal Hallamshire Hospital in Sheffield. All 
neurologists at the two sites were invited to participate (20 in Sheffield, 23 in Glasgow). 
Consecutive new and follow-up patients attending outpatient appointments between February 
and June 2012 in Glasgow, and April and September 2012 in Sheffield, with one of 14 
participating neurologists were approached. Out of all patients informed about the study, 223 
(66%) agreed to take part. Most patients (97.2% in Sheffield, 70.2% in Glasgow) were 
recruited in subspeciality rather than general neurology clinics (MS, epilepsy, neuromuscular, 
headache, neuro-oncology). All participants were 16 years or older. Only patients with 
capacity to give written informed consent and the ability to complete the post-interview 
questionnaires unaided were included.  
 
2.2 Data and Procedure 
 
The present data were collected as part of a larger study involving audio or video recording of 
consultations. Patients’ demographic characteristics were recorded in a Background 
Information questionnaire. As well as asking about age, gender and ethnicity, patients were 
also asked about their current employment status, and their highest qualifications.  Ethnicity 
was recoded into two groups: White British and Other.  Education was recoded from an 8 
category variable to a dichotomous variable, in which all patients were classified as either 
having post-school qualifications or not.  The employment variable employed distinguishes 
between those who are currently in work, and those who are not.  A further dummy variable 
codes for patients who are on leave or out of work due to disability or sickness, and those 
who are not.  
Post-appointment questionnaires were also completed by both neurologists and patients 
immediately after the clinical encounter.  The questionnaire for neurologists asked whether 
they had offered ‘a choice about treatment or further management’ (to which they could 
answer yes or no) and ‘to what extent are this patient’s symptoms explained by a 
medical/neurological disorder (for which they could choose between ‘completely / largely 
explained’, ‘partly explained / partly unexplained’ and ‘completely / largely unexplained’). 
They were also asked ‘how certain are you of  the diagnosis’, which they rated on a ten point 
scale ranging from very uncertain (1) to very certain (10).  
The patient questionnaires asked patients to state whether or not they had been offered 
“choice about any tests or treatment you might have or the next step in the management of your 
condition”, and included the Medical Interview Satisfaction Scale-21 (MISS-21).  A variable 
that described whether patients and doctors agreed whether choice had been offered was 
derived.  The categories of this variable were ‘Agree choice’ (i.e. both doctor and patient 
agree a choice was offered), ‘Agree no choice’, ‘Patient yes, doctor no’ (i.e. the patient 
believed a choice was offered but the doctor didn’t) and ‘Patient no, doctor yes’. Details 
about the characteristics and distributions of the above variables can be seen in Tables 1 and 
2. 
 
2.3 Measures 
 
The MISS-21, developed from the United States MISS-29 measure, has been validated for 
use in UK patient populations [26]. It is a well-established 21-item self-report tool, which 
uses provider-patient interactions as an index of quality and patients’ perceptions and 
attitudes regarding their consultations [27]. Respondents rate items on a seven-point Likert 
scale ranging from ‘very strongly disagree’ to ‘very strongly agree’.  Previous Factor 
analyses conducted using MISS-21 data have identified four subscales within this scale, 
which have been shown to represent discrete but overlapping aspects of satisfaction [26]. 
These four subscales have been labelled ‘distress-relief’, ‘communication comfort’, ’rapport’ 
and ‘compliance intent’. The MISS-21 has been found to have satisfactory internal reliability 
(Cronbach’s alpha values cited as between 0.67 and 0.92 for subscales) and scores have been 
found positively to correlate with satisfaction with previous appointments [26].   
 
2.4 Statistical Analysis 
 
 In view of the fact that the MISS-21 had not previously been used in neurology clinics, we 
initially carried out a factor analysis (principal components extraction with promax rotation) 
on the items captured by the MISS-21. A cut-off point of 0.5 was chosen to determine 
significant loading of particular items onto factors [28] (Table 3.) 
The relationships between the MISS-21, its factors, and the range of clinical and interactional 
variables shown in Tables 1 and 2 were examined using Pearson correlation coefficients for 
continuous variables and ANOVA for categorical variables (see Tables 4a and 4b). All of the 
clinical, demographic or interactional factors showing an association (at the 0.2 level) with 
overall patient satisfaction were subsequently entered into three multiple regression models to 
assess their contribution to the overall MISS-21 score and to its two most important subscores 
(see Table 5).  
Some individuals did not respond to all items on each questionnaire. For the purpose of 
analysing overall MISS-21 scores, missing values were replaced using median replacement if 
less than 10% of responses were missing from a particular patient. Replies with 10% or more 
of missing data were discounted. For other variables, listwise deletion was employed to deal 
with missing data. Information on the distribution of missing data can be seen in Table 1. 
 
3. RESULTS 
 
3.1 Sample characteristics 
 
Table 1 shows the demographic breakdown of the sample. While participants recruited in 
Glasgow were significantly younger and more likely not to be working because of illness, we 
could not discern any clinical or demographic differences between the patients at the two 
different sites that suggested it would not be appropriate to combine the datasets for the 
analyses conducted in this study. 
 
 
 
3.2 Choice 
 
3.2.1 Frequency of choice 
 
Patients perceived that they were given choice following 71.8% of encounters, whilst 
neurologists stated they had offered choice after 67.9% of encounters. Patients’ perceptions 
of choice were not associated with age, gender, ethnicity, educational achievements, 
employment status, appointment type (new or follow-up), whether or not they were 
accompanied, duration of the appointment, the clinician’s certainty in the diagnosis, or the 
clinician’s gender. However, patients who attended a general neurology clinic were more 
likely to perceive choice being offered than those who attended a subspecialist appointment 
(p=0.004, Chi-Square=9.895). Neurologists’ reports of whether they had offered choice were 
not associated with any of the demographic or clinical factors listed above. However, 
univariate analysis showed that offering choice was significantly associated with greater self-
reported diagnostic certainty [certainty level 8.7 (SD 1.5) vs. 8.0 (SD 2.2), p=0.006, 
(t=2.782)].   
 
3.2.2 Agreement about presence of choice 
 
Figure 1 shows the extent of doctor-patient agreement over whether choice was offered. Just 
over 50% of consultations were characterized as involving patient choice by both doctor and 
patient. Patients and clinicians disagreed after 32% of encounters about whether or not choice 
had featured in the appointment. An interrater reliability analysis using the Kappa statistic 
was performed to determine consistency between patients and doctors. The interrater 
reliability for patients and doctors was found to be Kappa = 0.24 (p =.001). While this shows 
a significant link between patient and doctor, a Kappa statistic between .21 and .4 indicates 
only a ‘fair’ level of agreement [29]. 
 
*Insert Figure 1 here please* 
 
 
 
3.3 Patient Satisfaction 
 
3.3.1 Factor Analysis 
 
The factor analysis in this study generated four factors. Table 2 shows the loading of the 
items on each of the four factors (three items on the MISS-21 did not contribute to any of the 
four factors identified). Two of the factors were very similar to the ‘rapport’ and ‘distress 
relief’ subscales identified in previous factor analyses of the MISS-21 [8]. Therefore, we also 
labelled these factors ‘rapport’ and ‘distress relief’. The remaining two subscales differed 
from those identified in previous research, and explained less variance in the model, so were 
not carried forward for further investigation. Reliability testing of the items loading onto the 
‘rapport’ and ‘distress relief’ factors showed both the retained subscales had high internal 
reliability (Cronbach’s alpha of 0.937 and 0.873 respectively). 
 
3.3.2 Bivariate analyses 
 
Tables 4a and 4b show the results of analyses examining the relationships between patient 
satisfaction as the dependent variable, and a number of other demographic, clinical and 
interactional variables, as well as variables measuring choice, as independent variables.  
Satisfaction was greater in the Sheffield sample, when doctors had greater diagnostic 
certainty, and when symptoms were considered ‘medically explained’. There were no 
significant correlations between satisfaction and patient’s age, gender or employment status, 
and the type of appointment (new versus follow-up). Satisfaction scores were not related to 
whether or not patients perceived that they had been offered choice and or whether clinicians 
believed that they had offered choice. Satisfaction scores were also unrelated to the multi-
category predictor describing whether or not patient and doctors agreed that choice had been 
offered. However, patient satisfaction was greater when neurologists and patients agreed that 
choice had not been offered, compared to all other options (F(1,172)=3.853, p=0.05).   
  
3.3.3 Multivariate analyses 
 
Table 5 shows the results of the three OLS Regression models that show the extent to which 
different variables explain variance in the ‘rapport’ and ‘distress relief’ subscales, as well as 
in MISS-21 scores as a whole. As well as replicating the bivariate finding that scores in 
Sheffield were significantly higher, this analysis also shows that when a clinician believed 
that symptoms were medically explained, this had a significant positive impact on patients’ 
ratings of ‘rapport’, and their overall MISS-21 score.  It is worth noting that if the three 
category ‘symptoms’ variable is treated as continuous, or dichotomised to distinguish 
between ‘unexplained’ and ‘partly explained / unexplained’ (results not shown here) then all 
three models show a significant association between ‘symptoms’ better explained by 
neurological disorder and greater patient satisfaction. These models also show that when 
clinicians were certain of the diagnosis, scores on the ‘distress-relief’ subscale were 
significantly higher. The bivariate finding that patient satisfaction was higher when patients 
and doctors both agreed choice had not been offered was not replicated in the multivariate 
analysis. 
 
4. DISCUSSION AND CONCLUSION 
 
4.1 Discussion 
 
4.1.1 Are patients offered choice? 
 
Our findings suggest that the neurologists included in this study have embraced NHS and 
GMC guidance on engaging patients in clinical decision-making processes and that patient 
choice features in over two thirds of clinical encounters in Glasgow and Sheffield neurology 
clinics, irrespective of demographic factors such as age and educational level. The fact that 
choice was perceived more commonly by patients who had attended general rather than 
subspecialist neurology appointments, and when clinicians reported greater certainty about 
their diagnosis, suggests that the reasons choice featured in interactions were more likely to 
be clinical than related to personal background or demographic factors.  
Having said this, it is striking that doctors and patients disagreed after 32% of appointments 
on whether choice had been given choice or not. This finding is in line with previous work on 
patients’ and clinicians’ perceptions of clinical encounters [30]. It suggests that it is difficult 
to objectify the concept of ‘patient choice’ in interaction. What is more, it demonstrates that it 
is not entirely straightforward for clinicians to provide patients with choice in a way that 
patients perceive as such. Preliminary qualitative work has provided some reasons why 
clinicians’ and patients’ views may diverge: for instance clinicians may use the “machinery” 
of choice (including a list of options followed by a question eliciting the patient’s view) 
whilst heavily ‘loading’ the list and actually making a strong recommendation, rather than 
offering a choice between evenly ‘balanced’ alternatives [31].   
 
4.1.2 Does choice lead to higher patient satisfaction? 
 
In this study we found no evidence that the provision or perception of choice increases 
patients’ satisfaction with the clinical encounter or the clinician. Indeed, initial analyses 
appeared to indicate that those consultations in which doctors and patients agreed that choice 
had not been provided were associated with higher overall satisfaction ratings than all other 
encounters (although this finding was not replicated in the multivariate analysis, when 
whether or not patient symptoms were medically explained was taken into account). Our 
preliminary Conversation Analytic study [21], in which five different major types of ‘no 
choice’ consultations were identified, could be of relevance here. The five different types 
were consultations in which: 1) No treatment was required because there was no medical 
problem; 2) nothing was offered because the medical problem was not neurological; 3) 
nothing needed to be done because no treatment was required for the neurological problem at 
present; 4) nothing needed to be done because treatment for the neurological problem had 
been exhausted; and 5) no change was needed because the treatment for the neurological 
problem was working. Analysis of these interactions suggests that decisions were actually 
made during these clinic appointments, but it seems that “no action” or “no change” decisions 
are often not recognised as a matter of choice by either party involved in the interaction. 
Nevertheless, it is worth noting that encounters in which such decisions were made left 
patients feeling more satisfied than those involving decisions about changes. 
The fact that ‘choice’ had no positive impact on patient satisfaction cannot be explained by a 
lack of sensitivity on the part of the MISS-21 instrument. While there is no universally 
accepted definition of ‘satisfaction’, measures like the MISS-21 are thought to capture an 
important dimension of the quality of care [32]. For instance, one study has shown that higher 
overall satisfaction ratings as measured by the MISS-21 were positively associated with 
subsequent symptom resolution [33]. In our study, in addition to the observation that patients 
expressed greater satisfaction after ‘agreed no choice’ encounters, patients reported greater 
satisfaction on the ‘distress-relief’ scale when the clinician was more certain about the 
diagnosis, providing some additional support for the sensitivity of the scale. Patients 
whose symptoms were considered ‘medically explained’ expressed greater satisfaction 
overall, as well as on the ‘rapport’ subscale, than those whose symptoms were thought 
‘medically unexplained’. This finding may reflect the fact that patients with ‘medically 
unexplained’ (or functional) neurological problems report a poor understanding of 
their symptoms [34]. They also tend to reject a psychological explanation of their 
symptoms and show marked interactional resistance when neurologists try to provide 
an explanation which links their symptoms with emotional or personal problems [35 
36]. It has been argued that the ‘rapport’ subscale of the MISS-21 has particular clinical 
relevance because studies using other measures have demonstrated that interactions in which 
physicians are perceived as being empathic, reassuring and as showing positive affect are 
associated with better patient outcomes [37-41]. The observation that patients with 
‘medically unexplained’ findings reported low satisfaction on this subscale could 
indicate that some neurologists have a less sympathetic attitude to these patients than 
those with ‘medically explained’ problems [42]. This subscale has previously been used in 
Conversation Analytic (CA) research and been shown to be sensitive to interactional features 
in primary care consultations [43].  
In our study, in addition to the observation that patients expressed greater satisfaction after 
‘agreed no choice’ encounters, patients reported greater satisfaction on the ‘distress-relief’ 
scale when the clinician was more certain about the diagnosis. Patients whose symptoms 
were considered ‘medically explained’ expressed greater satisfaction overall, as well as on 
the ‘rapport’ subscale, than those whose symptoms were thought ‘medically unexplained’. It 
has been argued that the ‘rapport’ subscale of the MISS-21 has particular clinical relevance 
because studies using other measures have demonstrated that interactions in which physicians 
are perceived as being empathic, reassuring and as showing positive affect are associated 
with better patient outcomes [34-38]. This subscale has previously been used in Conversation 
Analytic (CA) research and been shown to be sensitive to interactional features in primary 
care consultations [39]. In keeping with the findings of our study, CA studies have shown 
that consultations with patients whose symptoms are ‘medically unexplained’ are particularly 
challenging for both parties involved in the interaction [40 41].  
 
4.1.3 Limitations of the study 
 
Our study has a number of limitations. Although we captured the communication practice of 
14 neurologists and recruited a large number of patients from a wide range of different 
outpatient clinics in two neuroscience centres, it is not clear to what extent the findings of this 
study can be generalised to other medical settings. For instance, we are likely to have 
captured a patient cohort with a relatively high prevalence of chronic or complex disorders. 
Whilst it has been argued that patient involvement in decision-making is particularly 
important in such patient groups [7], it may be that patient satisfaction is influenced by other 
factors if presentations are related to more acute disorders. Our findings may also have been 
affected by a lack of clarity of what we meant by the term ‘choice’ in the questionnaires 
completed by patients and doctors. 
 
4.2 Conclusions 
 
Despite these limitations, our study demonstrates that, in line with the recommendations of 
the UK Department of Health and the General Medical Council, ‘patient choice’ features in 
the majority of clinical encounters in neurology outpatient appointments. However, doctors 
and patients often disagree about whether choice featured in the clinic interaction. There was 
no evidence that choice increased patient satisfaction.  
 
4.3 Practice Implications 
 
This study demonstrates that government policy and GMC guidance to implement patient 
choice are not easily realised in practice. Clinicians and their patients do not always have the 
same perception of what constitutes choice. Doctors need to be very explicit in their 
interactions if they want to be sure that the patient has understood that they are being given 
choice. Having said that, doctors should realise that ‘choice’ is not universally valued by all 
patients in all clinical scenarios. Importantly, the absence of ‘choice’ does not always indicate 
an absence of shared decision-making. Indeed, initial qualitative work on our dataset suggests 
that ‘choice’ might not be the defining feature of shared decision-making. Further work needs 
to be done to establish whether there are particular interactional scenarios in which patients 
value ‘choice’ more highly.  
Patients appear to value being given a certain and medically-based diagnosis for their 
symptoms. In situations where this is possible, patients rate their rapport with their clinician 
as greater, and their overall satisfaction as higher. 
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Figure 1. Did choice feature in the consultation? 
 
 
 
Note. P: Patient; D: Doctor; Y: Yes, there was choice; N: No, there was no choice 
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Table 1. Characteristics of consultations stratified by location.  
 
Sheffield Glasgow Combined Difference 
Glasgow 
vs. 
Sheffield 
Neurologists 
 
N 
Age (years) 
% Female 
 
 
 
7 
43.7 
42.9 
 
 
7 
41.4 
42.9 
 
 
14 
42.6 
42.9 
 
 
- 
n.s. 
n.s. 
 
 
Patients 
 
N 
Age (years) 
MISS-21 
% Female 
% White British 
 
 
 
109 
49.1 
101.0 
53.8 
89 
 
 
 
114 
41.4 
95.0 
65.8 
96.5 
 
 
 
223 
42.6 
98.0 
59.9 
92.8 
 
 
 
- 
** 
*** 
n.s. 
n.s. 
%Without post-
school 
qualifications 
% In work / 
education 
% On leave / out 
of work because 
of sickness / 
disability 
 
Consultations 
 
N 
Diagnostic 
certainty (1-10) 
% Accompanied 
% First 
appointment
 
% Seen in 
general clinics 
% Completely / 
largely explained 
% Partly 
explained, partly 
unexplained 
% Completely / 
largely 
unexplained 
% Patient 
perceived choice 
% Doctor 
perceived choice 
 
Patient / doctor 
agreement on 
choice 
 
N 
% Agree choice 
% Agree no 
choice 
% Patient yes 
doctor no 
% Patient no 
doctor yes 
39.2 
 
 
45.9 
 
16.7 
 
 
 
 
 
 
109 
8.27 
 
46.8 
26.7 
 
2.8 
 
72.5 
 
19.3 
 
 
3.7 
 
 
74.3 
 
 
66.0 
 
 
 
 
 
97 
52.6 
 
11.3 
 
14.0 
 
14.4 
31.0 
 
 
37.7 
 
33.3 
 
 
 
 
 
 
114 
8.65 
 
52.6 
32.1 
 
29.8 
 
53.5 
 
26.3 
 
 
17.5 
 
 
69.3 
 
 
69.6 
 
 
 
 
 
100 
55.0 
 
17.0 
 
21.6 
 
14.0 
 
34.9 
 
 
41.7 
 
25.3 
 
 
 
 
 
 
223 
8.47 
 
49.8 
29.3 
 
16.7 
 
62.8 
 
22.9 
 
 
10.8 
 
 
71.8 
 
 
67.9 
 
 
 
 
 
197 
53.8 
 
14.2 
 
17.8 
 
14.2 
 
n.s. 
 
 
n.s. 
 
** 
 
 
 
 
 
 
- 
n.s. 
 
n.s. 
n.s 
 
*** 
 
**a 
 
**a 
 
 
**a 
 
 
n.s. 
 
 
n.s. 
 
 
 
 
 
- 
n.s. a 
 
n.s. a 
 
n.s. a 
 
n.s. a 
 
    
***p≤.001, ** p≤.01, *p≤.05, ~p≤.10 
 
Note. Significance tests marked 
a
 show Chi square results of comparisons between all categories of the dependent variable in 
question. 
 
 
 
Table 2. Descriptive characteristics of continuous variables 
 
N Min Max Mean S.D. Skew Kurtosis 
Age 
Certainty 
Rapport 
Distress-
relief 
Total 
MISS-21 
 
 
221 
217 
184 
184 
 
189 
 
17 
1 
-2.35 
-3.04 
 
63 
 
80 
10 
1.36 
1.59 
 
132 
46.3 
8.5 
0 
0 
 
98.0 
15.3 
1.8 
.98 
.96 
 
11.0 
-.11 
-1.46 
-.26 
-.46 
 
-.08 
-.47 
2.65 
-1.35 
.30 
 
.88 
 
 
 
 
 
 
 
 
 
 
 
 
 
    
 
 
Table 3. Loadings of items of the MISS-21 on four factors generated by factor analysis.  
Item Rapport Distress-
Relief 
Doctor’s 
Understanding 
Communication 
Difficulties 
1.The Doctor told me just what my 
trouble is 
.052 .918* -.197 -.094 
2.After talking with the doctor, I 
know just how serious my illness 
is 
.090 .917* -.166 -.015 
3.The doctor told me all I wanted 
to know about my illness 
.107 .809* -.064 -.159 
4. I am not really certain about 
how to follow the doctor’s advice 
-.119 -.058 .116 .717* 
5. After talking with the doctor, I 
have a good idea how long it will 
-.312 .769* .352 .057 
be before I am well again 
6. The doctor seemed interested in 
me as a person 
.827* .107 .043 .146 
7. The doctor seemed warm and 
friendly to me 
.964* -.058 -.001 .060 
8. The doctor seemed to take my 
problems seriously 
.871* -.068 .027 -.112 
9. I felt embarrassed while talking 
with the doctor 
-.012 -.168 .007 .758* 
10. I felt free to talk to this doctor 
about private matters 
.732* -.057 .028 -.079 
11. The doctor gave me a chance 
to say what was really on my mind 
.867* -.024 .040 .021 
12. I really felt understood by my 
doctor 
.811* .102 .058 -.034 
13. The doctor did not allow me to 
say everything I had wanted about 
my problems 
-.226 .106 -.406 .212 
14. The doctor did not really 
understand my main reason for 
coming 
-.122 .118 -.616* .298 
15. This is a doctor I would trust 
with my life 
.499 -.006 .430 .062 
16. The doctor seemed to know 
what s/he was doing 
.663* .064 .117 -.124 
17. The doctor has relieved my 
worries about my illness 
-.046 .500* .582* .105 
18. The doctor seemed to know 
just what to do for my problem 
.245 .489 .350 .083 
19. I expect that it will be easy for 
me to follow the doctor’s advice 
.237 -.036 .740* .150 
20. It may be difficult for me to do 
exactly what the doctor told me to 
.165 .081 -.472 .564* 
do 
21. I’m not sure the doctor’s 
treatment will be worth the trouble 
it will take 
.091 .027 -.504* .411 
*Item loads on to this factor (>0.5) 
 
 
Table 4a. Satisfaction dimensions and continuous clinical / interactional variables.  
 
 Rapport Distress-Relief Overall 
MISS-21 
Score 
Age 
 
n 
Correlation 
183 
-0.070 
183 
0.056 
188 
.001 
 
p-value 0.346 0.454 
 
.998 
 
Diagnostic 
certainty  
n 
Correlation 
182 
-0.002 
182       
0.298*** 
187 
.131~ 
 
p-value 0.979 0.000 .074 
***p≤.001, ** p≤.01, *p≤.05, ~p≤.10 
 
 
 
 
 
 
 
 
Table 4b. Satisfaction dimensions and categorical clinical / interactional variables 
 
 
Rapport Distress Relief Overall MISS-21 
Mean t-test or 
ANOVA 
(p-value) 
Mean t-test or 
ANOVA 
(p-value) 
Mean t-test or 
ANOVA 
(p-value) 
Gender 
N  
Male 
Female 
 
Location 
N 
Sheffield 
Glasgow 
 
Ethnicity 
N 
 
184 
-.07 
.04 
 
 
184 
.32 
-.33 
 
 
175 
 
 
.47 
 
 
 
 
.00** 
 
 
 
 
 
184 
-.04 
.03 
 
 
184 
.28 
-.27 
 
 
175 
 
 
.53 
 
 
 
 
.00** 
 
 
 
 
 
189 
97.22 
98.47 
 
 
184 
101.0 
95.01 
 
 
180 
 
 
.45 
 
 
 
 
.00** 
 
 
 
 
White British 
Other (n=9) 
 
Education 
N 
Post-school 
qualifications 
No post-school 
qualifications 
 
Employment status 
N 
On leave – ill 
health 
Not on leave 
 
Accompanied? 
N 
Yes 
No 
 
First appointment? 
N 
Yes 
No 
 
Seen in general 
clinic? 
N 
Yes 
No 
 
Patient perceived 
choice 
N 
Yes 
No 
 
Doctor perceived 
choice 
N 
Yes 
No 
 
Choice a 
N 
Agree choice 
Agree no choice 
Patient yes doctor 
no 
-.01 
.11 
 
 
154 
.07 
 
.04 
 
 
 
184 
.14 
 
-.05 
 
 
184 
.08 
-.07 
 
 
145 
.068 
.02 
 
 
 
184 
-.27 
.05 
 
 
 
174 
.02 
-.05 
 
 
 
179 
.00 
-.00 
 
 
169 
.01 
-.09 
.06 
 
.74 
 
 
 
 
.84 
 
 
 
 
 
 
.24 
 
 
 
 
 
.32 
 
 
 
 
.78 
 
 
 
 
 
.11 
 
 
 
 
 
.69 
 
 
 
 
 
.97 
 
 
 
 
.84 
.63 
.74 
 
.02 
-.44 
 
 
154 
.04 
 
.09 
 
 
 
184 
-.01 
 
.00 
 
 
184 
-.01 
.01 
 
 
145 
-.05 
.08 
 
 
 
184 
-.21 
.04 
 
 
 
174 
.07 
-.10 
 
 
 
179 
.04 
-.11 
 
 
169 
.06 
-.25 
.09 
 
.16 
 
 
 
 
.73 
 
 
 
 
 
 
.91 
 
 
 
 
 
.89 
 
 
 
 
.40 
 
 
 
 
 
.20 
 
 
 
 
 
.29 
 
 
 
 
 
.32 
 
 
 
 
.42 
.16 
.63 
 
98.07 
96.22 
 
 
158 
99.37 
 
98.14 
 
 
 
189 
99.50 
 
97.46 
 
 
189 
98.71 
97.29 
 
 
150 
98.17 
98.85 
 
 
 
189 
94.63 
98.62 
 
 
 
179 
98.60 
97.02 
 
 
 
184 
98.17 
97.60 
 
 
174 
97.96 
94.17 
100.9 
 
.63 
 
 
 
 
.49 
 
 
 
 
 
 
.27 
 
 
 
 
 
.38 
 
 
 
 
.73 
 
 
 
 
 
.07~ 
 
 
 
 
 
.39 
 
 
 
 
 
.75 
 
 
 
 
.88 
.05~ 
.13 
 
Patient no doctor 
yes 
 
.01 .99 
 
 
-.03 .80 
 
99.78 .46 
Symptoms a 
N 
 
184 
  
184 
  
189 
 
Completely / 
largely explained 
.12 .03* .21 .00*** 99.91 .00** 
Partly explained, 
partly unexplained 
-.16 .22 -.42 
 
.00** 95.49 .09~ 
Completely /      
largely     
unexplained 
 
-.54 .01* -.48 .03* 91.10 .00** 
***p≤.001, ** p≤.01, *p≤.05, ~p≤.10 
 
Note. Significance tests for variables marked 
a
 show results of dichotomous dummy comparison of mean tests between the 
category in question and all other valid cases. 
 
 
 
Table 5. Series of regression models examining the relationship between satisfaction scores 
(MISS-21), characteristics of the clinician appointment and patient characteristics 
 
 
Rapport 
B(SE) 
(95% CI) 
Distress-Relief 
B(SE) 
(95% CI) 
 
MISS – 21  
B(SE) 
(95% CI) 
Location 
 
Patient ethnicity 
 
Seen in general clinic? 
 
 
Agreement on choice 
Agree no choice 
 
Agree choice 
 
Patient no doctor yes 
 
Symptoms 
Completely/ largely 
explained 
Partly explained, partly 
unexplained 
 
.60*** (.40) 
(.30 – .89) 
--   
--   
.00 (.20) 
(-.39 – .40) 
 
 
--   
--   
--   
--   
--   
--   
 
.26~ (.22) 
(-.18 – .70) 
.08 (.25) 
(-.40 – .56) 
.57** (.15) 
(.27 – .87) 
-.43 (.30) 
(-1.03 – .17) 
 .01 (.20) 
(-.40 – .39) 
 
 
.10 (.24) 
(-.57 – .38) 
-.03 (.18) 
(-.38 – .32) 
-.09 (.24) 
(-.57 – .38) 
 
.25 (.23) 
(-.25 – .64) 
-.80 (.24) 
(-.56 – .40) 
4.49* (1.75)     
(1.03 – 7.96) 
--   
-- 
2.62 (2.48) 
(-2.26 – 7.51) 
 
 
4.44 (2.82) 
(-1.13 – 10.02) 
2.97 (2.20) 
(-1.36 – 7.31) 
-.26 (2.89) 
(-5.95 – 5.44) 
 
5.50* (2.60) 
(.37 – 10.63) 
2.81 (2.79) 
(-2.69 – 8.31) 
    
Certainty 
 
-- 
-- 
   .12** (.05) 
(.04 - .21) 
.36 (.48) 
(-.57 – 1.30) 
N 168 167 172 
R-squared .119 .214 .146 
 
***p≤.001, ** p≤.01, *p≤.05, ~p≤.10 
 
Note. Reference groups for Symptoms and Agreement on choice categorical variables are Patient yes doctor no and 
Completely / largely unexplained. 
